Clinical Trial

Efficacy of CL25216 on Hormonal Balance and Menstrual Health in Women With Primary Dysmenorrhea.

Study acronym: PD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is to evaluate the effects of CL25216 on hormonal balance and menstrual health in women with primary dysmenorrhea. Enrolled subjects will receive either CL25216 - 250 mg/day or placebo.
Trial Details
NCT Number NCT07529561
Lead Sponsor ApexCPG LLC
Conditions Primary Dysmenorrhea, Menstural Cramps
Enrollment 80 participants
Start Date 2026-04-13
Primary Completion 2026-09-10 (estimated)
Study Completion 2026-09-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-14